|
⚲
|
| Keyboard |
| Lorient Capital Management LLC
✚
|
|
|---|---|
| CRD # | 289572 |
| SEC # | 801-117004 |
| CIK # | |
| AUM | 1,944.5 M (2026-03-30) |
| Employees | 29 (48% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 248-247-3900 |
| Address | 3250 Mary Street Miami, FL 33133 |
| Source | [IAPD] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 5: Fees and Compensation In general, Lorient receives a Management Fee (as defined below) and a carried interest in connection with the provision of advisory services to its clients. Lorient or other Lorient entities or affiliates receive additional compensation in connection with management and other services performed for portfolio companies of the Funds and such additional compensation will offset in whole or in part the Management Fees (as defined below) otherwise payable to Lorient to the extent provided by the Governing Documents. Investors in a Fund also bear certain expenses as further detailed below. Management Fees Certain of the Funds will pay Lorient a quarterly management fee (the “Management Fee”) payable in advance at the beginning of each calendar quarter equal to 2.0% per annum of each investor’s capital commitment or invested capital, as described in each Fund’s Governing Documents, as of the first day of the calendar quarter (the “Management Fee”). Notwithstanding the foregoing, the Management Fee may be reduced or waived by Lorient or the General Partners in their discretion. In addition to the Management Fee, the General Partners (or a principal of the General Partner) may receive a fee in connection with an investment by the Funds (e.g., a loan closing fee) or for ongoing services to a company that is an investment of the Funds (e.g., director fees for serving as a director of a portfolio company). Upon a date specified in the Governing Documents (the “Stepdown Date”), the Management Fee will be reduced and will equal 2.0% of (a) the aggregate invested contributions and unrecouped bridge financing contributions, as reduced by (b) permanent write downs and distributions constituting returns of capital. The Management Fee will be payable until proceeds from all portfolio investments are distributed or until Lorient’s relationship with the relevant Fund is terminated for other reasons (as described in the Governing Documents). Installments of the Management Fee payable for any period other than a full quarterly period are adjusted on a pro rata basis according to the actual number of days in such period. As a general matter, Management Fees will be payable during term extensions unless otherwise agreed with investors. As is generally the case in private equity funds, the Governing Documents provide that a Fund’s Management Fees will be calculated and charged on a basis that generally is not tied to the Fund’s then-current net asset value. As further specified in the Governing Documents, from the effective date of the relevant Fund until the Stepdown Date, Management Fees generally will be charged based on a formula tied to the amount of the relevant Fund’s aggregate invested contributions and unrecouped bridge financing contributions. Further, after the Stepdown Date, Management Fees generally will be charged and calculated based on a formula tied to the amount of aggregate invested contributions and unrecouped bridge financing contributions (including, where applicable, the amount of any capitalized Supplemental Fees (as defined below) or expenses, including costs of the Operations Team) or expenses made by the relevant Fund relating to the Fund’s aggregate investment(s) in its portfolio companies that have not been realized or completely written off in accordance with U.S. GAAP principles (such investments, “Impaired Value Investments”). Due to differences in the criteria set forth in their respective Governing Documents, in the event where more than one Fund participates in an investment, there is the possibility that an investment will become an Impaired Value Investment for purposes of one Fund’s Governing Documents but not those of one or more other Funds. As a result, and as is generally the case for private equity funds, the amount of Management Fees generally will not correspond with fluctuations in the net asset value of individual investments or of a Fund, including following the relevant investment period, and will not be reduced in connection with any write downs (whether temporary or permanent), except in the case of Impaired Value Investments. Except where the Governing Documents expressly provide to the contrary, Management Fees will not be reduced (in whole or in part) in the case of partial sales or dispositions, distributions (e.g., those resulting from a dividend recapitalization) or reorganizations, restructurings, roll-over investments, extraordinary dividends or similar transactions or in circumstances where one or more other Fund(s) divest their respective investment(s) in the relevant portfolio company, whether in whole or in part, in each case in circumstances that do not result in the complete disposition of the relevant Fund’s interest therein, and even in cases where the value of the Fund’s investment or the Fund’s ownership percentage in such investment has been reduced (including substantially reduced) as a result of such transaction. In many circumstances, the post-Stepdown Date Management Fee base will include capitalized transaction-specific fees and expenses of unrealized investments, including certain fees (such as Supplemental Fees) and expenses paid to Service Providers, the Operations Team, Lorient or its affiliates. Further, Management Fees generally will not be reimbursed or refunded under the Governing Documents in the event of realizations, dispositions or partial write-downs or write- offs that occur partway through the relevant calculation period. The Governing Documents set forth the full list of terms under which Management Fees will be reduced, offset or otherwise be limited, and consequently investors should expect to bear the full specified Management Fee rate in the Governing Documents until they are reduced in the circumstances and on the date(s) specified therein. To the extent specified in a Fund’s Governing Documents, Lorient or another Lorient entity will ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 7: Types of Clients Lorient provides investment advice solely to its Fund clients, and references throughout this Brochure to “clients” and to Lorient’s related duties to and practices on behalf of its clients and/or investors should be construed accordingly. The Funds generally include investment partnerships or other investment entities formed under and operated as exempt investment pools under the U.S. Investment Company Act of 1940, as amended (the “Investment Company Act”). The investors participating in the Funds generally include individuals, banks or thrift institutions, other investment entities, university endowments, sovereign wealth funds, family offices, pension and profit-sharing plans, trusts, estates or charitable organizations or other corporations or business entities and often include, directly or indirectly, principals or other personnel of Lorient and its affiliates and members of their families, the Operations Team or other Service Providers retained by Lorient or a Fund, as well as executives of portfolio companies. The relevant General Partner also generally is permitted to establish Funds that are alternative investment vehicles in order to permit certain investors to participate in one or more particular investment opportunities in a manner desirable for tax, regulatory or other reasons. Alternative investment vehicle sponsors generally have limited discretion to invest the assets of these vehicles independent of limitations or other procedures set forth in the organizational documents of such vehicles and the Governing Documents of the related Fund. Investors are generally “accredited investors” within the meaning of Rule 501(a) under the Securities Act of 1933, as amended (the “Securities Act”), and are generally either “qualified purchasers” within the meaning of Section 2(a)(51) under the Investment Company Act, or “qualified clients” within the meaning of Rule 205-3 under the Advisers Act. Each Fund generally has a minimum investment amount for third-party investors as provided in such Fund’s Governing Documents. Lorient generally is permitted to waive such minimum investment amount. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Lorient Phoenix Investment LP | [2025-03-28] | 87.7 M | |
| Filed 2024-02-23 (D) · Exemption 506(b) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Lorient Robin Investment LP | [2025-03-28] | 4.5 M | |
| Filed 2024-07-05 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Lorient Healthcare Fund III LP | [2024-03-27] | 14.7 M | 149.4 M |
| Filed 2024-10-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | LC II ABD Co-Invest LP | 2023-03-27 | 14.1 M | |
| PE | Lorient Peregrine Investment LP | [2023-03-27] | 226.0 M | 301.9 M |
| Offered $226,000,000 · Filed 2022-09-28 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Lorient Eagle Investment LP | [2022-03-31] | 4.1 M | 126.0 M |
| Offered $4,100,000 · Filed 2021-10-20 (D) · Exemption 506(b) · Duration One year or less · Net Assets Decline to Disclose | ||||
| PE | Lorient Healthcare Fund II LP | [2022-03-31] | 11.9 M | 328.5 M |
| Offered $11,860,000 · Filed 2021-03-24 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Lorient Healthcare Parallel Fund II LP | [2022-03-31] | 158.5 M | 204.9 M |
| Offered $158,500,000 · Filed 2021-10-12 (D/A) · Exemption 506(c), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Lorient Shiftkey Investment LP | [2022-03-31] | 25.0 M | 96.0 M |
| Offered $25,000,000 · Filed 2021-04-01 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Lorient VBF Co-Invest LP | [2022-03-31] | 12.5 M | |
| Offered $12,500,000 · Filed 2021-03-24 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 17 | 1,944.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 17 | 1,944.5 |
| By Discretionary | ||
| Discretionary | 17 | 1,944.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 17 | 1,944.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 1,944.5 | |
| Total | 17 | 1,944.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Mark Mitchell | Director | 61 | 6 | |
| David Berman | Director, Executive Officer | 44 | 3 | |
| Jordan Broome | Director, Executive Officer | 18 | 2 | |
| Lorient Healthcare GP II LLC | Director | 3 | 2 | |
| Lorient Eagle GP LP | Director | 2 | 2 | |
| Lorient Peregrine GP LLC | Director | 2 | 2 | |
| Lorient Healthcare GP III LLC | Executive Officer | 2 | 2 | |
| Lorient Shiftkey GP LLC | Director | 2 | 2 | |
| Lorient Phoenix GP LLC | Director | 1 | 1 | |
| Lorient Robin GP LLC | Director | 1 | 1 | |
| Lorient Healthcare GP LLC | Director | 1 | 1 | |
| Lorient Transitions LLC | Director | 1 | 1 | |
| Lorient Vbf GP LLC | Director | 1 | 1 | |
| Brian Rath | Executive Officer | 1 | 1 |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Comparable Firms | State | AUM |
|---|---|---|
|
CenterOak Adviser LP
✚
|
TX | 1,975.2 M |
|
FIC Partners Management LP
✚
|
TX | 1,967.0 M |
|
Brynwood Partners Management LLC
✚
|
CT | 1,964.5 M |
|
Ocean Avenue Capital Partners LP
✚
|
CA | 1,964.2 M |
|
Behrman Brothers Management Company LP
✚
|
NY | 1,948.2 M |
|
Capital Z Partners Management LLC
✚
|
FL | 1,944.7 M |
|
Brooke Private Equity Associates Management LLC
✚
|
MA | 1,942.8 M |
|
Entrepreneurial Equity Partners LP
✚
|
IL | 1,932.1 M |
|
Comvest PE Advisors LLC
✚
|
FL | 1,920.5 M |
|
Legalist Inc
✚
|
CA | 1,915.1 M |